US FDA's Internal Debate On Sage's Brexanolone Spills Into Open During Panel Review

 
• By Derrick Gingery

Bob Temple and Ellis Unger discuss feasibility of studies for postpartum depression drug as advisory committee members wait to discuss the dosing questions they had been convened to consider.

Psychiatric diagnosis Postpartum Depression. On psychiatrist workplace is medical certificate which indicated diagnosis of Postpartum Depression surrounded of questionnaire mental exam and hammer

More from US FDA Performance Tracker

More from Regulatory Trackers